399 related articles for article (PubMed ID: 10850296)
21. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma: technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study.
Fukumoto M; Yoshida D; Hayase N; Kurohara A; Akagi N; Yoshida S
Cancer; 1999 Oct; 86(8):1470-9. PubMed ID: 10526275
[TBL] [Abstract][Full Text] [Related]
22. Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomography.
Gratz S; Kempke B; Kaiser W; Behr TM; Pfestroff A; Höffken H
Nucl Med Commun; 2008 Nov; 29(11):963-9. PubMed ID: 18836374
[TBL] [Abstract][Full Text] [Related]
23. Thallium-201-chloride and technetium-99m-MIBI SPECT of primary and metastatic lung carcinoma.
Kashitani N; Makihara S; Maeda T; Eda R; Takeyama H; Hiraki Y
Oncol Rep; 1999; 6(1):127-33. PubMed ID: 9864415
[TBL] [Abstract][Full Text] [Related]
24. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
25. Intra-operative sentinel lymph node identification using a novel receptor-binding agent (technetium-99m neomannosyl human serum albumin, 99mTc-MSA) in stage I non-small cell lung cancer.
Kim S; Kim HK; Kang DY; Jeong JM; Choi YH
Eur J Cardiothorac Surg; 2010 Jun; 37(6):1450-6. PubMed ID: 20353895
[TBL] [Abstract][Full Text] [Related]
26. The role of positron emission tomography in mediastinal staging of patients with non-small cell lung cancer.
d'Amico A; Turska-d'Amico M; Jarzab B; Zielinski M
J Pak Med Assoc; 2015 Jan; 65(1):35-8. PubMed ID: 25831671
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m-tetrofosmin SPECT imaging of lung lesions: a not-so-negative study.
Schillaci O; Picardi V; Scopinaro F
J Nucl Med; 1998 Oct; 39(10):1830. PubMed ID: 9776298
[No Abstract] [Full Text] [Related]
28. The role of 99mTc-tetrofosmin scintigraphy for staging patients with laryngeal cancer.
Fattori B; Grosso M; Nacci A; Bianchi F; Cosottini M; Ursino F; Manca G; Rubello D; Strauss HW; Mariani G
Cancer Biother Radiopharm; 2005 Feb; 20(1):27-35. PubMed ID: 15778576
[TBL] [Abstract][Full Text] [Related]
29. The usefulness of Tc-99m-tetrofosmin SPECT/CT in the detection of residual tumors and axillary lymph node metastases in breast cancer patients following neoadjuvant therapy.
Spanu A; Sanna D; Chessa F; Farris A; Nuvoli S; Madeddu G
Clin Nucl Med; 2011 Nov; 36(11):997-1002. PubMed ID: 21975387
[TBL] [Abstract][Full Text] [Related]
30. [201T1 single photon emission computed tomography in the diagnosis of lung cancer].
Tonami N; Hisada K; Watanabe Y; Suzuki M; Takashima T; Nonomura A; Kitagawa M
Rinsho Hoshasen; 1990 Jul; 35(7):825-32. PubMed ID: 2169553
[TBL] [Abstract][Full Text] [Related]
31. Sentinel node identification in clinical stage Ia non-small cell lung cancer by a combined single photon emission computed tomography/computed tomography system.
Nomori H; Ikeda K; Mori T; Shiraishi S; Kobayashi H; Iwatani K; Kawanaka K; Kobayashi T
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):182-7. PubMed ID: 17599506
[TBL] [Abstract][Full Text] [Related]
32. The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection.
Spanu A; Tanda F; Dettori G; Manca A; Chessa F; Porcu A; Falchi A; Nuvoli S; Madeddu G
Q J Nucl Med; 2003 Jun; 47(2):116-28. PubMed ID: 12865872
[TBL] [Abstract][Full Text] [Related]
33. Technetium-99m-tetrofosmin imaging of lung cancer: relationship with histopathology.
Takekawa H; Shinano H; Tsukamoto E; Koseki Y; Ikeno T; Miller F; Kawakami Y
Ann Nucl Med; 1999 Apr; 13(2):71-5. PubMed ID: 10355949
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m-tetrofosmin scintigraphy, P-glycoprotein and lung cancer.
Tabuenca MJ; Vargas JA; Varela A; Salas C; Durántez A; Ortiz Berrocal J
J Nucl Med; 1998 Oct; 39(10):1830-1. PubMed ID: 9776299
[No Abstract] [Full Text] [Related]
35. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement.
Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M
Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801
[TBL] [Abstract][Full Text] [Related]
36. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m-tetrofosmin scintigraphy in patients with metastatic soft tissue sarcoma.
Karanikas G; Köstler WJ; Becherer A; Wiesner K; Dudczak R; Krainer M; Kletter K
Oncol Rep; 2002; 9(5):1009-13. PubMed ID: 12168065
[TBL] [Abstract][Full Text] [Related]
38. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
39. [New trials for improving diagnostic accuracy of stress technetium-99m-tetrofosmin single photon emission computed tomography].
Sasaki R; Mitani I; Kitamura Y; Nemoto T; Tsukahara K; Tanaka Y; Higuma K
J Cardiol; 2002 Jan; 39(1):11-7. PubMed ID: 11828793
[TBL] [Abstract][Full Text] [Related]
40. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
